Thus, the higher requirement of α-adrenergic receptor blockers in patients with pheochromocytoma harboring the rs553668 polymorphisms of the ADRA2A gene could be due to a lower presynaptic receptor density. Here, ADRA2A is linked to hereditary pheochromocytoma-paraganglioma.